Amneal Pharmaceuticals to acquire Kashiv BioSciences in biosimilar deal
Amneal Pharmaceuticals Inc. (NASDAQ: AMRX) has entered into a definitive agreement to acquire Kashiv BioSciences LLC, according to a press ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
